What HHL holds.
Harvest Healthcare Leaders Income ETF, as published by Harvest ETFs.
Positions 21
Top ten 50.2%
Largest 5.3% REGN
Gross exposure 99.1% unlevered
It holds other funds
HHL is a fund of funds: 1 of its 21 positions are themselves ETFs. That means you pay its fee on top of theirs, and owning one of them separately doubles you up rather than diversifying.
TBIL Harvest Canadian T-Bill ETF 0.4%
Companies
| Symbol | Company | Weight |
|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | 5.3% |
| BSX | Boston Scientific Corporation | 5.1% |
| BMY | Bristol-Myers Squibb Company | 5.1% |
| AMGN | Amgen Inc. | 5.0% |
| ELV | Elevance Health, Inc. | 5.0% |
| MRK | Merck & Co., Inc. | 5.0% |
| TMO | Thermo Fisher Scientific Inc. | 5.0% |
| ABT | Abbott Laboratories | 4.9% |
| A | Agilent Technologies, Inc. | 4.9% |
| AZN | AstraZeneca PLC | 4.9% |
| DHR | Danaher Corporation | 4.9% |
| ISRG | Intuitive Surgical, Inc. | 4.9% |
| JNJ | Johnson & Johnson | 4.9% |
| MDT | Medtronic PLC | 4.9% |
| NVS | Novartis AG | 4.9% |
| UNH | UnitedHealth Group Incorporated | 4.9% |
| VRTX | Vertex Pharmaceuticals Incorporated | 4.9% |
| ABBV | AbbVie Inc. | 4.8% |
| LLY | Eli Lilly and Company | 4.8% |
| SYK | Stryker Corporation | 4.6% |
As at 2026-08-10. Each symbol links to which other covered funds hold it. Cash and liability lines (1.2%, 0.3%, 0.8%) are excluded — on a levered fund the cash line is negative.
Allocation
Sector Allocation
Pharmaceuticals 29.6%
Health Care Equipment & Supplies 24.4%
Biotechnology 20.0%
Life Sciences Tools & Services 14.8%
Health Care Providers & Services 9.9%
Cash Equivalents 0.4%
Geographic Allocation
United States 98.7%
Canada 0.4%
See where your funds overlap.
Hold two of these and some of it is the same company twice. Import your holdings and every underlying position is rolled up across funds.